Medications for Osteosarcoma

10 results
Slate Run Pharmaceuticals, LLC
Usage: Leucovorin calcium is indicated for rescue after high-dose methotrexate therapy in osteosarcoma, to reduce toxicity from methotrexate overdosage, treat megaloblastic anemia due to folic acid deficiency, and as an adjunct with 5-fluorouracil in palliative treatment of advanced colorectal cancer.
Sagent Pharmaceuticals
Usage: Leucovorin calcium is indicated as a rescue therapy after high-dose methotrexate in osteosarcoma, to reduce toxicity from methotrexate or folic acid antagonist overdosage, treat megaloblastic anemias, and enhance survival in advanced colorectal cancer when used with 5-fluorouracil (separate infusions needed).
Fosun Pharma USA Inc.
Usage: Levoleucovorin injection is indicated for rescue after high-dose methotrexate therapy in osteosarcoma, to reduce toxicity from methotrexate and folic acid antagonist overdosage, and in combination with 5-fluorouracil for palliative treatment of advanced metastatic colorectal cancer. Not for use in pernicious or megaloblastic anemia.
Fresenius Kabi USA, LLC
Usage: Methotrexate is indicated for treating various neoplastic diseases, including choriocarcinoma, leukemia, breast cancer, and advanced lymphomas, as well as for severe psoriasis and rheumatoid arthritis, particularly in patients unresponsive to first-line therapies. Proper diagnosis and monitoring are essential for effective treatment.
Accord Healthcare, Inc.
Usage: Methotrexate Injection is indicated for treating various conditions, including acute lymphoblastic leukemia, meningeal leukemia, Non-Hodgkin lymphoma, osteosarcoma, breast cancer, squamous cell carcinoma of the head and neck, gestational trophoblastic neoplasia, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and severe psoriasis.
Hikma Pharmaceuticals USA Inc.
Usage: Methotrexate is indicated for treating neoplastic diseases such as gestational choriocarcinoma, leukemias, various cancers (breast, head and neck, lung), advanced non-Hodgkin’s lymphomas, severe psoriasis, and rheumatoid arthritis in patients unresponsive to first-line therapies. It is used alone or in combination with other agents.
SOFIE Co. dba SOFIE
Usage: Sodium Fluoride F18 Injection is indicated for diagnostic PET imaging of bone to assess areas of altered osteogenic activity.
Cardinal Health 414, LLC
Usage: Sodium Fluoride F-18 Injection, USP, is indicated for diagnostic positron emission tomography (PET) imaging of bone, specifically to identify areas of altered osteogenic activity.
The University of Utah DBA Cyclotron Radiochemistry Lab Huntsman Cancer Institute
Usage: Sodium Fluoride F 18 Injection, USP is indicated for diagnostic positron emission tomography (PET) imaging of bone to identify regions of altered osteogenic activity.
Biomedical Research Foundation of Northwest Louisiana
Usage: Sodium Fluoride F 18 Injection, USP is indicated for diagnostic positron emission tomography (PET) imaging of bones to identify areas of altered osteogenic activity.